Response of adrenocortical carcinoma liver metastases to hepatic artery infusion floxuridine.

[1]  M. D'Angelica,et al.  Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network. , 2022, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  Ash A. Alizadeh,et al.  Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. , 2021, Cancer discovery.

[3]  K. Reilly,et al.  Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma , 2021, Current oncology.

[4]  T. Fojo,et al.  Long‐term outcomes in patients with advanced adrenocortical carcinoma after image‐guided locoregional ablation or embolization , 2021, Cancer medicine.

[5]  M. D'Angelica,et al.  Hepatic artery infusion pumps , 2020, Journal of surgical oncology.

[6]  M. Berger,et al.  PD-1 Blockade in Advanced Adrenocortical Carcinoma. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Raja R. Narayan,et al.  Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[8]  C. Schade-Brittinger,et al.  Combination chemotherapy in advanced adrenocortical carcinoma. , 2012, The New England journal of medicine.

[9]  S. Steinberg,et al.  Operative management for recurrent and metastatic adrenocortical carcinoma , 2012, Journal of surgical oncology.

[10]  M. Schlumberger,et al.  5‐Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma , 1991, Cancer.